Saturday, November 23, 2024
Subscribe American Journal of Medicine Free Newsletter
CardiologySalt, No Salt, or Less Salt for Patients With Heart Failure?

Salt, No Salt, or Less Salt for Patients With Heart Failure?

 

Restricting dietary sodium is a common recommendation given by clinicians to patients with heart failure and is one supported by current guidelines. However, the quality of evidence for this recommendation is suboptimal, and there is no consensus on the optimal level of sodium intake. Though excessive sodium intake is associated with left ventricular hypertrophy and hypertension, recent data have suggested that very low sodium intake is paradoxically associated with worse outcomes for patients with heart failure. This is possibly explained by the association between low sodium intake and activation of the sympathetic and renin-angiotensin-aldosterone systems. Nevertheless, sodium restriction is routinely recommended and remains a cornerstone of heart failure and blood pressure therapy. In this review we discuss the pros and cons of sodium restriction for patients with heart failure from the current literature.

The prevalence of heart failure is increasing and now affects more than 25 million people globally.1, 2 Restricting dietary sodium is a common recommendation given by physicians to patients with heart failure. On average, Americans consume 3500-4000 mg of dietary sodium every day.3 All current international heart failure guidelines recommend restriction in sodium intake.4, 5, 6, 7, 8, 9, 10, 11, 12 However, the level of evidence in these guidelines is either not provided or is derived from expert opinion and lacks of high-quality data (Grade C; Table 1). Guidelines recommend sodium restriction ranging from 1500 to 3000 mg/d and reflect a lack of consensus on the maximum sodium intake.

To read this article in its entirety please visit our website.

-Muhammad Shahzeb Khan, MDa, Daniel W. Jones, MD, MACP, FAHAb, Javed Butler, MD, MPH, MBAb

This article originally appeared in the January 2020 issue of The American Journal of Medicine.

Latest Posts

lupus

Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man

A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flue Vaccine

Flu Vaccination to Prevent Cardiovascular Mortality (video)

0
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
varicella zoster

Varicella Zoster Virus-Induced Complete Heart Block

0
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Racial justice in healthcare

Teaching Anti-Racism in the Clinical Environment

0
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
Invisible hand of the market

The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs

0
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
Joseph S. Alpert, MD

New Coronary Heart Disease Risk Factors

0
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiovascular risk from noncardiac activities

Cardiac Risk Related to Noncardiac & Nonsurgical Activities

0
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine. Cardiovascular risk...